Flexible Solutions International, Inc. (NYSE Amex: FSI) reported its financial results for the second quarter of 2025. Sales and net income showed positive growth compared to the same period last year.
The company highlighted the impact of R&D revenue, tariff increases, and growth in the food and nutrition supplement manufacturing markets on its performance during the quarter.
Key contributors to revenue and cash flow were the NanoChem division and ENP subsidiary, with a focus on expanding product production in Panama and Illinois.
Sales Growth
Q2 2025 sales reached $11,367,132, marking an 8% increase from the same period in 2024.
Net Income Increase
Q2 2025 net income was $2,028,912, up from $1,289,796 in Q2 2024, driven by various factors including R&D services sales.
Operating Cash Flow
The company's 6 months operating cash flow for 2025 was $4,253,875, demonstrating improved financial performance year over year.
- Despite headwinds such as tariff increases, Flexible Solutions International saw positive growth in sales and net income during Q2 2025.
- The company's focus on expanding production facilities and entering new markets, particularly in food and nutrition supplements, has contributed to its overall financial success.
Flexible Solutions International's performance in the second quarter of 2025 reflects steady growth and strategic expansion in key markets. The company's ability to navigate challenges while capitalizing on growth opportunities positions it well for future success.